Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New program aims to ease mental and physical side effects of immunotherapy

NCT ID NCT05715255

First seen May 30, 2026 · Last updated Jun 17, 2026 · Updated 6 times

Summary

This study tests a personalized self-management program to help cancer survivors on immune checkpoint inhibitors better handle side effects and reduce anxiety or depression. About 400 adults with breast, colon, lung, skin, or rectal cancer who recently started immunotherapy will take part. Participants will report symptoms weekly and receive guidance to manage them, with the goal of improving quality of life and reducing treatment disruptions.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Arizona Cancer Center

    RECRUITING

    Tucson, Arizona, 85724, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Email: •••••@•••••

  • University of Michigan

    ACTIVE_NOT_RECRUITING

    Ann Arbor, Michigan, 48109, United States

  • Valleywise Health Medical Center

    ACTIVE_NOT_RECRUITING

    Phoenix, Arizona, 85008, United States

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm colon carcinoma colonic neoplasm lung cancer lung neoplasm neoplasm rectal cancer rectal neoplasm skin cancer skin neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.